Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non-squamous NSCLC
ClinicalTrials.gov study NCT02852798. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status
ClinicalTrials.gov study NCT07094893. IPD Sharing: NO. Countries: 0. Publications: 0.
Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases
ClinicalTrials.gov study NCT06483672. IPD Sharing: NO. Countries: 0. Publications: 0.
EGFR Mutation Detection From Advanced NSCLC Patient Tissue and Plasma in EGFR-TKI Treatment
ClinicalTrials.gov study NCT02644889. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI
ClinicalTrials.gov study NCT03984071. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC Treatment
ClinicalTrials.gov study NCT04970043. IPD Sharing: NO. Countries: 0. Publications: 0.
A Phase II Study of Anti-EGFR Antibody-drug Conjugate (ADC) Combine With CDK4/6 Inhibitors Posterior Line in the Treatment of Recurrent/Metastatic CDKN2A Gene Variant Head and Neck Squamous Cell Carci
ClinicalTrials.gov study NCT06509997. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Vebreltinib Plus PLB1004 Versus Platinum-based Doublet Chemotherapy in Patients With EGFRm, MET+, Locally Advanced or Metastatic NSCLC Following EGFR-TKI Failure
ClinicalTrials.gov study NCT06970782. IPD Sharing: NO. Countries: 0. Publications: 0.
Sacituzumab Tirumotecan (Sac-TMT) Plus Bevacizumab in 3rd Generation EGFR-TKI Treated Advanced EGFR-mutant Nonsquamous NSCLC With Brain Metastasis
ClinicalTrials.gov study NCT07197008. IPD Sharing: NO. Countries: 0. Publications: 0.
Anlotinib Hydrochloride as Second-line Therapy in Elderly Patients With EGFR Wild-type Lung Adenocarcinoma
ClinicalTrials.gov study NCT03728374. IPD Sharing: NO. Countries: 0. Publications: 0.
European Physician Survey of EGFR Inhibitor Prescribing Patterns
ClinicalTrials.gov study NCT01652833. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Combination of Local Therapy and Target Therapy for Brain Metastases With EGFR Mutation
ClinicalTrials.gov study NCT05616377. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism
ClinicalTrials.gov study NCT03002844. IPD Sharing: NO. Countries: 0. Publications: 0.
The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR
ClinicalTrials.gov study NCT02493582. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation
ClinicalTrials.gov study NCT03754530. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.
ClinicalTrials.gov study NCT06018688. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT07177092. IPD Sharing: NO. Countries: 0. Publications: 0.
CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
ClinicalTrials.gov study NCT04933422. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT01732276. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
ClinicalTrials.gov study NCT06110663. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.